Editing Retroperitoneal Lymph Node Dissection

Revision as of 11:50, 19 December 2021 by Urology4all (talk | contribs) (Created page with "* Principles of RPLND (template, limits, nerve-sparing, etc.) are applied, regardless of the intent to administer adjuvant chemotherapy or approach (open vs. minimially-invasive) * Patients who are candidates for RPLND should be referred to an experienced surgeon at a high-volume center. ** Surgeons with experience in the management of GCT and expertise in minimally invasive surgery may offer a minimally-invasive RPLND, acknowledging the lack of long-term data on oncolo...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Warning: You are editing an out-of-date revision of this page. If you publish it, any changes made since this revision will be lost.
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see UrologySchool.com:Copyrights for details). Do not submit copyrighted work without permission!
Cancel Editing help (opens in new window)